Erythematous maculopapular eruption due to ribavirin administration in a patient with chronic hepatitis C.
Okai
Takashi
T
Shirasaki
Fumiaki
F
Sawabu
Norio
N
D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D016898:Interferon-alpha; D008297:Male; D008875:Middle Aged; D010267:Parapsoriasis / Q000139:chemically induced*; D011994:Recombinant Proteins; D012254:Ribavirin / Q000009:adverse effects* / Q000627:therapeutic use
D000998:Antiviral Agents; D007370:Interferon Type I; D016898:Interferon-alpha; D011994:Recombinant Proteins; C076799:interferon-alpha 8; D012254:Ribavirin